Literature DB >> 32797425

Aseptic Cryoprotectant-Free Vitrification of Human Spermatozoa by Direct Dropping into a Cooling Agent.

Mengying Wang1, Evgenia Isachenko1, Gohar Rahimi1, Peter Mallmann1, Vladimir Isachenko2.   

Abstract

Spermatozoa cryopreservation is used for the management of infertility and some other medical conditions. Routinely applied cryopreservation techniques depend on permeating cryoprotectants and relatively slow freezing rates. Cryoprotectant-free vitrification is an alternative and cost-effective method that is based on rapid cooling of spermatozoa by direct plunging into a cooling agent to prevent lethal intracellular ice crystallization and the detrimental effects of high salt concentrations. One of the problems with this technique is that full sterilization of commercially produced liquid nitrogen, which could be contaminated with different pathogens, is not possible. Here we use a benchtop device for the production of sterile liquid air with the same temperature as liquid nitrogen (-195.7 °C). This has been used to develop aseptic technology for cryoprotectant-free vitrification of human spermatozoa.

Entities:  

Keywords:  Aseptic; Human spermatozoa; Liquid air; Liquid nitrogen; Vitrification

Mesh:

Substances:

Year:  2021        PMID: 32797425     DOI: 10.1007/978-1-0716-0783-1_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Vitrification of human spermatozoa without cryoprotectants.

Authors:  F Nawroth; V Isachenko; S Dessole; G Rahimi; M Farina; N Vargiu; P Mallmann; M Dattena; G Capobianco; D Peters; I Orth; E Isachenko
Journal:  Cryo Letters       Date:  2002 Mar-Apr       Impact factor: 1.066

2.  Risk management in cryopreservation associated with assisted reproduction.

Authors:  M Tomlinson
Journal:  Cryo Letters       Date:  2008 Mar-Apr       Impact factor: 1.066

3.  Effect of sample freezing on the isolation of Mycoplasma spp. from the clitoral fossa of the mare.

Authors:  V Bermudez; R B Miller; W Johnson; S Rosendal; L Ruhnke
Journal:  Can J Vet Res       Date:  1988-01       Impact factor: 1.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.